Exagen Inc. (XGN): Total Liabilities
$40.57M
As of 2025-12-31
$39.72M
As of 2026-06-30
-2.5%
3-year compound annual growth
+2.1%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.57M | +15.4% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $35.15M | +2.6% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $34.25M | -21.7% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $43.76M | +13.6% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $38.51M | +5.4% | 2023-03-20, Balance as of period end |
| 2020-12-31 | $36.54M | +11.9% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $32.65M | -8.3% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $35.62M | n/a | 2020-03-25, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Exagen Inc. (XGN) | 2025-12-31 | $40.57M | +15.4% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $72.98M | +8.4% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
| CapForce Inc. (CFOR) | 2025-12-31 | $6.20M | +149.7% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $344.15M | -28.3% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.79M | -7.9% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗